Newsletter
Dear Investor
Investing in shares or bonds is always an adventure with risk which can be reduced by subscribing to the “Confidential Investment Review“. The team behind the Review have analysed industrial and commercial companies quoted on the Swiss and the major stock exchanges in Europe from which we have selected our own portfolio. From this analysis one can get an in-depth view of a company and its relative share price, which is very different from annual directories or looking at stock-picking models. Spending a few minutes reading this newsletter may be to your advantage.
The Review goes behind published figures and statements and determines the economic reality of the performance of a business. Certain indicators enable our researchers to identify techniques used to enhance profit and hence earnings per share. It must be stated that the Review does not criticise companies nor their auditors, as it would not serve any useful purpose. Comments made are for the sole purpose of assisting subscribers and giving them information based on facts.
Use the “Confidential Investment Review“ to evaluate shares which you may have in your portfolio or in our proposals for investment.
We look at investment from a purely business point of view which reflects business reality.
What you will receive each month by subscribing
to the “CONFIDENTIAL INVESTMENT REVIEW“:
Each month we will recommend 10 shares for investment from our portfolio and there will be a review of the company on each share proposed. We do not guess at company performance but evaluate its target share price based on facts and not trends of share prices.
Our unique Share Price Evaluation Method – Intelligent Investing
We are confident that the “CONFIDENTIAL INVESTMENT REVIEW“ can be of assistance to you in your investment activities. Once the Subscription Order Form is received by us, duly completed and signed, we will send you the first of twelve copies of the "Confidential Investment Review“. We will invoice you on a quarterly basis in advance. You have the right to cancel your subscription and the unused part of your subscription payment will be refunded.
With the recent debacles in the corporate scene with the consequent impact on share prices, corporate health assessment is essential for investors. We look forward to having you or your organisation as a subscriber to the “CONFIDENTIAL INVESTMENT REVIEW“.